Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01716338 · ClinicalTrials.gov registry record · Phase 1
Glyburide Healthy Volunteer Study
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01716338 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants.
The verdict
NCT01716338, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Glyburide is a medication that has been safely used for several decades to treat non-insulin dependent diabetes. This pilot study seeks to evaluate whether glyburide, administered at the lowest dose (1.5 mg/dL daily) to healthy (non-diabetic) subjects is safe both physically and cognitively. The investigators are hopeful that the results of this study will provide the necessary foundation to evaluate this medication's use on a larger scale to determine the feasibility of using glyburide in soldiers either prophylactically or for the treatment of brain injury.
Interventions
- DRUG Placebo
- DRUG Glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01716338
The ClinicalTrials.gov registry entry for NCT01716338 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01716338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01716338 about?
NCT01716338 is a clinical study titled "Glyburide Healthy Volunteer Study". Glyburide is a medication that has been safely used for several decades to treat non-insulin dependent diabetes. This pilot study seeks to evaluate whether glyburide, administered at the lowest dose (1.5 mg/dL daily) to healthy (non-diabetic) subjects is safe both physically and cognitively. The inv...
What is the current status of trial NCT01716338?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2013-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01716338?
The interventions under investigation include: Placebo (DRUG), Glyburide (DRUG).
Who is sponsoring clinical trial NCT01716338?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.